Ligand Pharmaceuticals
LGND
#3462
Rank
โ‚ฌ3.37 B
Marketcap
169,47ย โ‚ฌ
Share price
-4.03%
Change (1 day)
70.44%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): โ‚ฌ0.13 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.26 Billion. , an increase over its 2024 earnings that were of โ‚ฌ4.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.14 B2848.57%
2024 โ‚ฌ4.81 M-91.37%
2023 โ‚ฌ55.75 M-7.59%
2022 โ‚ฌ60.33 M4%
2021 โ‚ฌ58.01 M296.42%
2020 โ‚ฌ14.63 M-97.97%
2019 โ‚ฌ0.72 B275.62%
2018 โ‚ฌ0.19 B237.48%
2017 โ‚ฌ56.92 M49.05%
2016 โ‚ฌ38.19 M55.41%
2015 โ‚ฌ24.57 M36.87%
2014 โ‚ฌ17.95 M29.59%
2013 โ‚ฌ13.85 M1309.35%
2012 โ‚ฌ0.98 M-43.97%
2011 โ‚ฌ1.75 M-113.19%
2010 -โ‚ฌ13.31 Million59.86%
2009 -โ‚ฌ8.33 Million-61.33%
2008 -โ‚ฌ21.52 Million-58.75%
2007 -โ‚ฌ52.17 Million20.52%
2006 -โ‚ฌ43.29 Million81.27%
2005 -โ‚ฌ23.88 Million
2003 -โ‚ฌ16.63 Million-20.6%
2002 -โ‚ฌ20.94 Million4.38%
2001 -โ‚ฌ20.06 Million-48.83%
2000 -โ‚ฌ39.2 Million-19.74%
1999 -โ‚ฌ48.84 Million-19.06%
1998 -โ‚ฌ60.34 Million126.71%
1997 -โ‚ฌ26.62 Million-5.83%
1996 -โ‚ฌ28.27 Million136.23%
1995 -โ‚ฌ11.97 Million-33.97%
1994 -โ‚ฌ18.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ29.08 B 20,399.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ8.83 B 6,126.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ22.30 B 15,620.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.78 B 5,384.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.44 Billion-408.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.43 B 13,599.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.08 B 5,599.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ8.57 B 5,945.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ53.65 Million-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA